Rutgers researchers say the risk is low, but patients should still be aware of the possible association. GLP-1 medications have become widely used for Type 2 diabetes and obesity, with drugs such as semaglutide, sold as Ozempic and Wegovy, and tirzepatide, sold as Mounjaro and Zepbound, among the best-known examples. The drugs can also reduce […]This is a curated summary.